These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35117880)

  • 1. Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients.
    Li C; Lu F; Lei T; Yu H; Yang H
    Transl Cancer Res; 2020 Sep; 9(9):5139-5146. PubMed ID: 35117880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy.
    Li C; Lu F; Lei T; Yu H; Chen X; Peng S; Han S; Yang H
    BMC Cancer; 2020 Aug; 20(1):742. PubMed ID: 32770971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis.
    Liu C; Zhang X; Zhu Y; Wei J; Ye X; Yang C; Tong H; Mai W; Yang M; Qian J; Mao L; Meng H; Jin J; Yu W
    Ann Hematol; 2023 Sep; 102(9):2387-2395. PubMed ID: 37278748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.
    Huang YC; Liu CJ; Liu CY; Pai JT; Hong YC; Teng HW; Hsiao LT; Chao TC; Gau JP; Liu JH; Hsu HC; Chiou TJ; Chen PM; Yu YB; Tzeng CH
    Ann Hematol; 2011 Oct; 90(10):1145-51. PubMed ID: 21647583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemotherapeutic increase of peripheral absolute monocyte count predicts interstitial pneumonia in lymphoma patients.
    Lang M; Yu J; Wang X; Song Z; Li L; Qiu L; Zhang H
    Hematol Oncol; 2018 Dec; 36(5):779-785. PubMed ID: 30144117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma.
    Liu WP; Wang XP; Zheng W; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Zhang C; Deng LJ; Ding N; Wang XG; Song YQ; Zhu J
    Ann Hematol; 2018 Jan; 97(1):133-139. PubMed ID: 29086010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab.
    Kurokawa T; Kaya H; Yoshida T
    J Clin Exp Hematop; 2010; 50(2):159-62. PubMed ID: 21123974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple blood parameters may serve as a warning to immunochemotherapy-related interstitial lung disease in B-cell lymphoma.
    Xia F; Liu H; Zhang H; Ping N; Wang P; Jin Z; Zhu J; Qu C
    Ann Palliat Med; 2021 Sep; 10(9):9660-9668. PubMed ID: 34628891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma.
    Katsuya H; Suzumiya J; Sasaki H; Ishitsuka K; Shibata T; Takamatsu Y; Tamura K
    Leuk Lymphoma; 2009 Nov; 50(11):1818-23. PubMed ID: 19863173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphoma.
    Kato H; Yamamoto K; Taji H; Oki Y; Chihara D; Seto M; Kagami Y; Morishima Y
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):483-9. PubMed ID: 21978956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy.
    Hashimoto K; Kobayashi Y; Asakura Y; Mori M; Azuma T; Maruyama D; Kim SW; Watanabe T; Tobinai K
    Leuk Lymphoma; 2010 Oct; 51(10):1816-21. PubMed ID: 20919860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
    Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
    Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab.
    Salmasi G; Li M; Sivabalasundaram V; Panzarella T; Tsang R; Kukreti V; Crump M; Kuruvilla J
    Leuk Lymphoma; 2015 Jun; 56(6):1659-64. PubMed ID: 25356925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.
    Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
    Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pneumocystis pneumonia prophylaxis with low-dose trimethoprim/sulfamethoxazole during rituximab-containing chemotherapy].
    Shimizu R; Sakemura R; Iwata S; Hayakawa H; Miyao K; Kajiguchi T
    Rinsho Ketsueki; 2019; 60(5):365-371. PubMed ID: 31167996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not all bad: Drug-induced interstitial pneumonia in DLBCL patients is potentially fatal but could be linked to better survival.
    Wei W; Zhu Y; Tang J; Xu C; Li J; He S; Zhang Z; Wu P; Luo L; Guo Q; Li F; Ren Y; Yu S; Li R; Li L
    Leuk Res; 2021 Dec; 111():106688. PubMed ID: 34450501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy.
    Kim T; Choi SH; Kim SH; Jeong JY; Woo JH; Kim YS; Sung H; Kim MN; Yoon DH; Suh C; Lee SO
    Ann Hematol; 2013 Jan; 92(2):231-8. PubMed ID: 23053189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
    Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
    J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.